Business
BioVaxys acquires TAETSoftware to utilize Trial Adverse Events Tracker platform
(NewsDirect) BioVaxys CEO James Passin joins Natalie Stoberman from the Proactive newsroom to...
About this update from Biovaxys Technology Corp
[{"type":"text","content":"BioVaxys acquires TAETSoftware to utilize Trial Adverse Events Tracker platform\n \n \n (NewsDirect)\n \n \n BioVaxys CEO James Passin joins Natalie\nStoberman from the Proactive newsroom to discuss the company's\nacquisition of TAETSoftware, a Vancouver-based clinical studies\nmanagement company engaged in the development and commercialization of\nthe Trial Adverse Events Tracker (TAET) technology platform.\n \n \n Passin says the acquisition of TAETCO provides BioVaxys with a\nthird low-risk near-term revenue generating product, supporting its\ncore business in cancer and viral vaccine development.\n \n \n \n \n \n Contact\nDetails\n \n \n \n Proactive Canada\n \n \n +1 604-688-8158\n \n \n \n [email protected]\n \n \n \n Copyright (c) 2023 TheNewswire - All rights reserved.\n \n \n","length":1136,"tagName":"div"}]